UK HealthTech Success: Norwich-based Evaro Raises $25m

There is some fantastic news for the UK HealthTech sector this week.

Evaro, a Norwich-based digital health platform, has announced a $25m (£18m) Series A funding round led by AlbionVC.

Founded by husband-and-wife team Dr. Thuria Wenbar and Dr. Oskar Wenbar, the company has spent the last seven years quietly building something essential: the "regulatory plumbing" of digital healthcare.

"Healthcare-as-a-Service"

Evaro operates an NHS-licensed platform that allows consumer brands—such as the period-tracking app Clue and retailer Lovehoney—to embed regulated healthcare services directly into their user experience.

Rather than just offering a consultation, Evaro provides the full stack: asynchronous consultations, prescribing, and dispensing, all backed by CQC and GPhC licenses.

Dr. Thuria Wenbar puts it perfectly:

"We're making healthcare as accessible as online banking... helping people get the care they need while supporting NHS capacity."

Why This Matters for the Industry

What is significant here is what the investors are buying. AlbionVC Partner Christoph Ruedig noted that Evaro’s competitive advantage is the "depth of their regulatory stack."

They didn't just build a user interface; they spent seven years building the hard, unglamorous infrastructure that ensures safety and compliance.

This raise is a validation of a broader trend we are seeing across the market in 2026: Infrastructure is the new innovation.

Whether in consumer health or the NHS supply chain, the companies that succeed aren't just those with the best ideas—they are the ones with the operational backbone to handle the heavy lifting of regulation.

Congratulations to the Evaro team on a major win for regional UK tech.